US 8598139
Lipid formulated dsRNA targeting the PCSK9 gene
granted A61KA61K31/713A61K38/1709
Quick answer
US patent 8598139 (Lipid formulated dsRNA targeting the PCSK9 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/713, A61K38/1709, A61K47/545, A61K47/55